Geriatric Mental Health in Maplewood, NJ

Late-life depression is common and often under-treated. Presentations in older adults frequently differ from younger adults — cognitive complaints, somatic symptoms (pain, fatigue, GI issues), and apathy may be more prominent than verbalized sadness. Treatable. SSRIs are first-line; we dose conservatively and watch specific side effects closely. For medically complex patients, medication selection requires attention to drug-drug interactions, renal and hepatic function, and the anticholinergic burden that builds up across a patient’s full medication list.

Late-life anxiety disorders — generalized anxiety disorder, panic disorder, adjustment disorders with anxious features, anxiety secondary to medical illness — affect a substantial portion of older adults and produce real functional impact. Treatable. We prefer SSRIs and SNRIs (escitalopram, sertraline, duloxetine, venlafaxine) and use benzodiazepines very cautiously given their well-documented fall risk, delirium risk, and cognitive side effects in older adults.

Dementia-related behavioral and psychological symptoms— agitation, aggression, wandering, sleep disruption, paranoid ideation, depression-plus-dementia, anxiety-plus-dementia — are among the most common reasons older adults come to psychiatric care. First-line management is non-pharmacological (environmental modifications, routine, caregiver education); medications are considered when non-pharmacological approaches don’t meet clinical need, with careful attention to antipsychotic risks in dementia.

Grief and bereavement are not mental illness, but they sometimes cross into major depression, prolonged grief disorder (now a DSM-5-TR diagnosis), or treatable anxiety. We distinguish normal bereavement from pathological grief and offer appropriate support without over-medicalizing natural loss.

Sleep disorders are extremely common in older adults and often contribute to cognitive, mood, and safety problems. We evaluate for obstructive sleep apnea (under-diagnosed in this age group), restless legs syndrome, REM behavior disorder (which can precede Lewy body dementia), and primary insomnia. Targeted treatment of the specific sleep problem often produces broader mood and cognitive improvement.

Substance use disorders — alcohol use disorder, prescription-medication misuse (benzodiazepines, opioids), and occasionally late-onset substance problems — affect older adults and are under-screened. We screen at intake and coordinate with addiction services when indicated.

Late-onset bipolar and psychosis do occur and warrant careful workup. First-episode mania or psychotic symptoms after age 65 require medical and neurological evaluation before settling on a primary psychiatric diagnosis, since they can be secondary to medications, metabolic derangements, or early dementia.

Older adults metabolize and distribute medications differently than younger adults. Renal function declines with age, reducing clearance of medications cleared by the kidneys. Hepatic metabolism slows. Body composition shifts toward lower lean mass and higher fat mass, which changes distribution of lipophilic medications. Plasma protein binding decreases, increasing free drug concentration for highly protein-bound medications. The overall result: therapeutic doses in a 70-year-old are typically lower than in a 40-year-old, and side effects often emerge at doses that would be routine in younger adults.

“Start low, go slow” is the universal principle. We typically start antidepressants and anxiolytics at half the usual starting dose in older adults, titrate more slowly, and aim for the lowest effective dose rather than the typical target dose. This preserves efficacy while reducing side-effect burden.

Orthostatic hypotension — a drop in blood pressure on standing — is a specific concern because it produces falls, and falls in older adults produce fractures, hospitalizations, and downstream mortality. Several psychiatric medications (tricyclic antidepressants, low-potency antipsychotics, alpha-blockers) can worsen orthostatic hypotension; we screen for it at baseline, avoid or minimize medications that worsen it, and coordinate with primary care on cardiovascular medications that may contribute.

Anticholinergic burden is the cumulative sedating, cognitively impairing, and delirium-precipitating effect of medications with anticholinergic activity. Many common medications contribute — antihistamines, tricyclic antidepressants, older antipsychotics, bladder-overactivity medications, some GI medications. Beyond a threshold, anticholinergic burden is associated with worsened cognition, increased dementia risk, and delirium precipitation. We explicitly review the full medication list at intake and flag high-anticholinergic medications for potential deprescribing with your primary-care clinician.

Cardiovascular and QT-interval monitoring matters more in older adults because baseline cardiovascular disease is more prevalent. Citalopram at higher doses, some antipsychotics, and certain antidepressant-medication combinations can prolong the QT interval and produce arrhythmia risk. Baseline EKG is indicated for patients with cardiovascular disease or on multiple QT-prolonging medications.

The Beers Criteria — published by the American Geriatrics Society — identifies medications that should generally be avoided or used with caution in older adults due to elevated risk of falls, delirium, cognitive impairment, and other adverse outcomes. We use Beers as a reference and explain our reasoning when we’re recommending against a medication.

Benzodiazepines (alprazolam/Xanax, clonazepam/Klonopin, lorazepam/Ativan, diazepam/Valium) are associated with substantially increased fall risk, cognitive impairment, delirium, and dependence in older adults. Paradoxical disinhibition and agitation can occur. Current practice is to avoid initiating benzodiazepines in older adults, to taper chronic benzodiazepine use slowly when clinically appropriate, and to use non-benzodiazepine anxiolytics (buspirone, SSRIs) as first-line for chronic anxiety.

Paroxetine (Paxil) has the highest anticholinergic load of the SSRIs and is also highly CYP2D6-inhibiting. We typically use sertraline, escitalopram, or duloxetine instead. Fluoxetine (Prozac)has a long half-life that can accumulate in older adults and occasionally produces activation and agitation; it’s not typically first-line in this age group.

Tricyclic antidepressants (amitriptyline, nortriptyline, imipramine) have high anticholinergic load and cardiac effects; they are generally avoided in older adults except in very specific circumstances. First-generation antipsychotics (haloperidol, chlorpromazine) carry higher extrapyramidal risk in older adults; atypicals are preferred when antipsychotics are needed. Zolpidem (Ambien) and similar Z-drugs for sleep carry fall and delirium risk comparable to benzodiazepines and are generally avoided; we prefer addressing sleep via mirtazapine when clinically appropriate, or non-pharmacological sleep interventions.

Caregivers of older adults with mental health or cognitive conditions bear a substantial load — emotional, logistical, financial. Caregiver burden is associated with elevated depression risk, anxiety, and health problems in caregivers themselves. Supporting the caregiver is not optional; it’s part of supporting the patient.

With patient consent, we welcome family members in visits — not for every visit, not as a replacement for the patient’s voice, but for the portions where collateral history, caregiving-logistics conversations, or education about a diagnosis or medication plan matters. For patients with dementia, family involvement is often essential.

For caregivers who are themselves struggling — with anxiety, depression, grief about the loss of the parent they knew, or the specific exhaustion of caregiving — we can refer for individual care or to the caregiver support groups in the Essex County area. Resources: the NJ Division of Aging Services (1-877-222-3737) operates the NJ Caregiver Support Program; the Alzheimer’s Association 24/7 helpline (1-800-272-3900) is a strong resource for dementia-specific caregiver questions; several Maplewood-area senior centers run caregiver groups.

Older adults are often portrayed as uncomfortable with technology. In our experience that framing is frequently wrong — many older adults engage comfortably with video visits, particularly once past an initial orientation. Where they struggle is with the kind of logistical demands that in-person visits impose: transportation, walking distances, waiting rooms, transfer from car to office. Telehealth removes those demands without removing the clinical relationship.

For mobility-limited patients, telehealth is often the difference between accessing care and not accessing care. For patients using walkers, wheelchairs, or home oxygen, the physical logistics of an office visit are themselves a barrier. For patients whose transportation depends on adult children or friends, telehealth eliminates the scheduling coordination that often makes in-person visits unsustainable.

Family support for telehealth — having an adult child or spouse help set up the visit the first few times, confirm audio and video are working, and be available if technical issues arise — works well. Once the visit is running, they can step out for the private portion and return for the parts where family participation is welcome. We talk through this setup at the first visit.

Medicare and NJ Medicaid may cover eligible telehealth psychiatric visits, but coverage, cost-sharing, managed-care rules, and visit requirements depend on the specific plan and current rules. We verify benefits before the first paid visit so older adults and families know what to expect.

Initial evaluation with older adults runs longer than with younger adults — typically 75–90 minutes rather than 60. There is more medical history to review, more medications to account for, more social context to understand, and more reason to take diagnostic humility seriously. The first visit usually ends with a working diagnosis and a first-step treatment plan, sometimes with additional workup (labs, MoCA, neurology or primary-care coordination) before finalizing the full plan.

Follow-up cadence during titration is every 2–4 weeks; maintenance visits are typically every 1–3 months. Visits are substantive — 30–45 minutes covering mood, anxiety, sleep, cognitive status, medication tolerance, orthostatic symptoms, falls, and life stressors. For patients on lithium or certain mood stabilizers, we follow standing laboratory monitoring.

Family involvement — with patient consent — is commonly part of geriatric psychiatric care. An adult child might join the last 15 minutes of a visit to hear the medication plan, the warning signs to watch for, and the questions to bring to primary care. A spouse or partner might attend early visits to provide collateral history. Patient consent comes first; the patient’s voice anchors every visit.